Literature DB >> 1196131

Dissociation of calcium and sodium clearances in patients with hypoparathyroidism by infusion of chlorothiazide.

L S Costanzo, A M Moses, K J Rao, I M Weiner.   

Abstract

Previous reports have identified a deficient hypocalciuric response to chronic treatment with thiazide diuretics in patients with hypoparathyroidism. The present study was designed to ascertain if the acute response to thiazide diuretics is impaired in hypoparathyroidism. Five normal subjects and five patients with hypoparathyroidism were studied with the renal clearance technique during water diuresis. In normal subjects the clearance of calcium/clearance of sodium was 0.98 +/- 0.14 before, and 0.33 +/-0.03 during the intravenous infusion of chlorothiazide. In patients with hypoparathyroidism the corresponding ratios were 1.69 +/- 0.27 and 0.57 +/- 0.10. In both groups the drug-induced fall in clearance was 65% of control. The concentration of chlorothiazide in plasma and its rate of excretion were comparable in both groups. It is concluded that the acute action of thiazides is not impaired in hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1196131     DOI: 10.1016/0026-0495(75)90052-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism.

Authors:  G H Newman; M Wade; D J Hosking
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Impaired renal calcium absorption in mice lacking calcium channel beta 3 subunits.

Authors:  José F Bernardo; Clara E Magyar; W Bruce Sneddon; Peter A Friedman
Journal:  Can J Physiol Pharmacol       Date:  2009-07       Impact factor: 2.273

3.  The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.

Authors:  K Mizunashi; Y Furukawa; K Abe; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.